Overview

Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The study design of this trial is open-label, randomized, multi-center, parallel-group study.
Phase:
Phase 4
Details
Lead Sponsor:
Handok Inc.
Handok Pharmaceuticals Co., Ltd.
Treatments:
Metformin
Vildagliptin